Cargando…
Towards understanding aromatase inhibitory activity via QSAR modeling
Aromatase is a rate-limiting enzyme for estrogen biosynthesis that is overproduced in breast cancer tissue. To block the growth of breast tumors, aromatase inhibitors (AIs) are employed to bind and inhibit aromatase in order to lower the amount of estrogen produced in the body. Although a number of...
Autores principales: | Shoombuatong, Watshara, Schaduangrat, Nalini, Nantasenamat, Chanin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123608/ https://www.ncbi.nlm.nih.gov/pubmed/30190660 http://dx.doi.org/10.17179/excli2018-1417 |
Ejemplares similares
-
Unraveling the bioactivity of anticancer peptides as deduced from machine learning
por: Shoombuatong, Watshara, et al.
Publicado: (2018) -
Prediction of aromatase inhibitory activity using the efficient linear method (ELM)
por: Shoombuatong, Watshara, et al.
Publicado: (2015) -
Probing the origin of estrogen receptor alpha inhibition via large-scale QSAR study
por: Suvannang, Naravut, et al.
Publicado: (2018) -
ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides
por: Schaduangrat, Nalini, et al.
Publicado: (2019) -
Meta-iAVP: A Sequence-Based Meta-Predictor for Improving the Prediction of Antiviral Peptides Using Effective Feature Representation
por: Schaduangrat, Nalini, et al.
Publicado: (2019)